References
Archived Content
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please "contact us" to request a format other than those available.
1. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalagia 2013; 33(9): 629-808.
2. Stovner L, Hagen K, Jensen R, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalagia 2007; 27: 193-210.
3. Schramm AH, Obermann M, Katsarava Z, et al. Epidemiological profiles of patients with chronic migraine and chronic tension-type headache. The Journal of Headache and Pain 2013; 14: 40.
4. Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet 2012; 380(9859): 2163-96.
5. Manack AN, Buse DC, Lipton RB. Chronic migraine: Epidemiology and disease burden. Current Pain and Headache Reports 2011; 15: 70-8.
6. Merikangas KR. Contributions of epidemiology to our understanding of migraine. Headache 2013; 53(2): 230-46.
7. Dorland’s Illustrated Medical Dictionary. Philadelphia, Pennsylvania: W.B. Saunders Co., 1994.
8. O’Brien B, Goeree R, Streiner D. Prevalence of migraine headache in Canada: A population-based survey. International Journal of Epidemiology 1994; 23(5): 1020-6.
9. Cooke LJ, Becker WJ. Migraine prevalence, treatment and impact: the Canadian women and migraine study. Canadian Journal of Neurological Sciences 2010; 37: 580-7.
10. Stovner LJ, Andrée C. Prevalence of headache in Europe: a review for the Eurolight project. Journal of Headache and Pain 2010; 11: 289-99.
11. Smitherman TA, Burch R, Sheikh H, Loder E. The prevalence, impact and treatment of migraine and severe headaches in the United States: A review of statistics from National Surveillance Studies. Headache 2013; 53(3): 427-36.
12. Ertas M, Baykan B, Orhan EK, et al. One-year prevalence and the impact of migraine and tension-type headache in Turkey: a nationwide home-based study in adults. Journal of Headache Pain 2012; 13: 147-57.
13. Matias-Guiu J, Fernandez C, Porta-Etessam J, et al. Factors associated with the differences in migraine prevalence rates between Spanish regions. The Scientific World Journal 2014; article ID 323084, 6 pages.
14. Pfaffenrath V, Fendrich K, Vennemann M, et al. Regional variations in the prevalence of migraine and tension-type headache applying the new IHS criteria: the German DMKG Headache Study. Cephalagia 2009; 29(1): 48-57.
15. Stovner LJ, Al Jumah M, Birbeck GL, et al. The methodology of population surveys of headache prevalence, burden and cost: Principles and recommendations from the Global Campaign against Headache. The Journal of Headache and Pain 2014; 15: 5.
16. Lipton RB, Dodick D, Sadovsky R, et al. A self-administered screener for migraine in primary care: The ID MigraineTM validation study. Neurology 2003; 61(3): 375-82.
17. Rapoport AM, Bigal ME. ID-migraine. Neurological Sciences 2004; 24: S258-60.
18. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine 2001; 16(9): 606-13.
19. Rao JNK, Wu CFJ, Yue K. Some recent work on resampling methods for complex surveys. Survey Methodology (Statistics Canada, Catalogue 12-001) 1992; 18(2): 209-17.
20. Rust KF, Rao JNK. Variance estimation for complex surveys using replication techniques. Statistical Methods in Medical Research 1996; 5: 281-310.
21. Serrano D, Manack AN, Reed ML, et al. Cost and predictors of lost productive time in chronic migraine and episodic migraine: Results from the American Migraine Prevalence and Prevention (AMPP) Study. Value in Health 2013; 16: 31-8.
22. Breslau N, Lipton RB, Stewart WF, et al. Comorbidity of migraine and depression: investigating potential etiology and prognosis. Neurology 2003; 60: 1308-12.
23. Jette N, Patten S, Williams J, et al. Comorbidity of migraine and psychiatric disorders: a national population-based study. Headache 2008; 48(4): 501-16.
24. Bigal ME, Lipton RB. The epidemiology, burden, and comorbidities of migraine. Neurologic Clinics 2009; 27(2): 321-34.
25. Bruti G, Magnotti MC, Iannetti G. Migraine and depression : bidirectional co-morbidities? Neurological Sciences 2012; 33(Suppl .1): S107-9.
26. Stokes M, Becker WJ, Lipton RB, et al. Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS). Headache 2011; 51: 1058-77.
27. Sanderson JC, Devine EB, Lipton RB, et al. Headache-related health resource utilisation in chronic and episodic migraine across six countries. Journal of Neurology, Neurosurgery and Psychiatry 2013; 84: 1309-17.
28. Stewart WF, Wood GC, Razzaghi H, et al. Work impact of migraine headaches. Journal of Occupational and Environmental Medicine 2008; 50: 736-45.
- Date modified: